By PPN News Staff
A retrospective database analysis of U.S. veterans with hepatitis C virus and a high incidence of comorbidities showed that elbasvir-grazoprevir (Zepatier, Merck) achieved a high sustained virologic response (SVR) rate, according to a presentation at the International Liver Congress 2017, in Amsterdam.
The researchers conducted the analysis of 2,436 chronic HCV patients in the Department of Veterans Affairs (VA) health care system, identified from the VA Corporate Data